title: Evaluation of CD34 antigen expression following tamoxifen as primary treatment for breast cancer.
authors.affiliation: Department of Gynecology, Federal University of Piauí, Teresina, Piauí, Brazil. beneditoborges@globo.com
authors.forename: B B
authors.initials: BB
authors.lastname: da Silva
authors.forename: E R
authors.initials: ER
authors.lastname: de Carvalho Gonçalves Nunes Galvão
authors.forename: L G
authors.initials: LG
authors.lastname: Dos Santos
mesh_terms: D018952:Antigens, CD34 / Q000032:analysis*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000276:immunology; D018270:Carcinoma, Ductal, Breast / Q000098:blood supply / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D009389:Neovascularization, Pathologic / Q000188:drug therapy / Q000276:immunology; D015996:Survival Rate; D013629:Tamoxifen / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D018952:Antigens, CD34; D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen